Medical Edge from Mayo Clinic
www.medicaledge.org
 
Medical Edge
  About
  Television
  Radio
  Newspaper
  Participating Newspapers
  Magazine
  Contact
 
  About Mayo Clinic
  Make an Appointment at Mayo Clinic
 

Medical Edge Newspaper Column from Mayo Clinic

SWITCHING TO NEW ANTIPSYCHOTIC DRUG MAY RELIEVE SYMPTOMS

DEAR MAYO CLINIC: I was diagnosed with schizophrenia nearly 20 years ago, and have taken haloperidol (Haldol) and trifluoperazine (Stelazine) pretty much since then. Mentally, I’ve done very well — I have not been hospitalized since 1992 — but the medications cause my mouth and tongue to move uncontrollably. Can anything be done for these side effects? I cannot afford a more expensive medication. — Seattle, Wash.

ANSWER: Your doctor should first refer you to a neurologist, who may discover some other cause of these symptoms. But you most likely have tardive dyskinesia — involuntary movements of the mouth, lips, tongue and other parts of the body — a well-known side effect of long-term treatment with the drugs that you have been taking.

These conventional antipsychotic drugs — which also include chlorpromazine (Thorazine), fluphenazine (Prolixin), thiothixene (Navane), perphenazine (Trilafon) and thioridazine (Mellaril) — have been used since the 1950s. They’ve been very helpful to schizophrenia patients because they reduce hallucinations (sensing things that don’t exist, such as imaginary voices) and delusions (personal beliefs not based in reality). But they can have unpleasant side effects.

In the last decade or so, a major new treatment for schizophrenia has been the new-generation antipsychotic drugs such as aripiprazole (Abilify), risperidone (Risperdal), olanzapine (Zyprexa), quetiapine (Seroquel) and ziprasidone (Geodon). These medications are less likely to cause TD, and they tend to alleviate the secondary symptoms of the schizophrenia — dulled emotions, apathy and alterations in speech — that the conventional agents don’t affect so well. The new-generation drugs may also relieve the TD caused by previous conventional-drug therapy. But the new drugs have side effects of their own, such as weight gain, other metabolic changes and a propensity to develop diabetes.

Whether to use the conventional or new-generation drugs depends on the particulars of the case, the specific side effects experienced and the patient’s preferences. But given the likelihood that your TD symptoms will worsen over time on the present regimen, it might make sense for you to try to switch to one of the new-generation drugs, especially as your positive history with Haldol and Stelazine suggests that you could do well with them.

The most effective of these new antipsychotics is clozapine (trade name Clozaril). Unfortunately, it has serious side effects that require close monitoring of the white blood cell count to make sure that the immune system is not compromised. Most other new-generation medications have actually been developed in an attempt to replicate clozapine’s benefits without its side effects, but scientists haven’t been able to accomplish both goals.

Still, these medications often work quite nicely for many people. Current treatment guidelines for recently diagnosed schizophrenia recommend that patients first try one or more of the other new-generation drugs, and later resort to clozapine only if necessary.

The new antipsychotics are very expensive, but they might not unduly burden your budget. For one thing, people with major psychiatric illnesses, including schizophrenia, are generally eligible for governmental assistance. Also, numerous state, county and manufacturers’ programs exist to help patients pay for the drugs. And individuals’ own health insurance plans may include the new-generation antipsychotic drugs in their formularies and require co-pays for them that are no higher than those of the conventional medications.

Your doctor may be able to recommend a social worker or case manager to help you navigate these complex financial issues. The outcome for you, financially and medically, could well be favorable.

— Timothy W. Lineberry, M.D., Psychiatry and Psychology, Mayo Clinic, Rochester, Minn.

Additional Resources:
Treating Schizophrenia
Appointment Information
More Information on Schizophrenia

- - -

Medical Edge from Mayo Clinic is an educational resource and doesn’t replace regular medical care. To e-mail a question, go to www.mayoclinic.org, or write: Medical Edge from Mayo Clinic, c/o TMS, 2225 Kenmore Ave., Suite 114, Buffalo, N.Y., 14207. For health information, visit www.mayoclinic.com.

© 2005 TRIBUNE MEDIA SERVICES, INC.

 

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE
USE OF THIS SITE SIGNIFIES YOUR AGREEMENT TO THE TERMS OF USE
Copyright © 1996-2004 Mayo Foundation for Medical Education and Research.